ArticleCancers2024

Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia.

Tzu-Ting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.